New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.
Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it can—and cannot—do in the brain’s early months, offering clearer expectations for caregivers.
NEW RESEARCH: A diabetes medication already helping millions, called Jardiance, improves memory, strengthens blood flow, and supports overall brain health in pre- and early Alzheimer’s.
IMAGINE THIS: Instead of going to an infusion center for treatment, you can switch to a weekly injection at home. That’s now a reality for many Alzheimer’s patients.
PRODUCT OF THE WEEK: Caregivers love this pill box, as do patients and professionals. Simply fill it once a month. Roomy, simple, ingenious.
Caring for someone with Alzheimer’s is demanding enough. Now, instead of traveling for hours of infusions, families can turn to Leqembi IQLIK—a once-weekly injection approved by the FDA that makes treatment simpler, safer, and closer to home.
They’re not just pills—they’re precision infusions designed to slow Alzheimer’s at its source. See UCLA’s cutting-edge Amyloid Immunotherapy Care Program, and what it feels like to begin treatment with Leqembi (lecanemab) and Kisunla (donanemab).
Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.
FDA approves a newly recommended dosing schedule for Kisunla (Donanemab). It’s significantly safer due to lowered ARIA-E rates, which has been the main problem with these drugs.
Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?
A fascinating study in Europe finds that individuals who felt they had memory problems did in fact have measurable cognitive deficits. Scientists analyzed the spinal fluid to measure the levels of biomarkers associated with Alzheimer’s.
A diet that combines unsaturated fats with nitrite-rich vegetables, such as olive oil and lettuce, can protect you from hypertension and vascular dementia.
Most of the time, it takes a combination of genetics, bad environment and unhealthy lifestyle to trigger Alzheimer’s. However, one gene called apolipoprotein E (APOE) can make a big difference.
Don’t put that controller down just yet. Playing three-dimensional video games – besides being lots of fun – can boost the formation of memories, according to University of California neurobiologists.
A fascinating study in Europe finds that individuals who felt they had memory problems did in fact have measurable cognitive deficits. Scientists analyzed the spinal fluid to measure the levels of biomarkers associated with Alzheimer’s.
A diet that combines unsaturated fats with nitrite-rich vegetables, such as olive oil and lettuce, can protect you from hypertension and vascular dementia.
Most of the time, it takes a combination of genetics, bad environment and unhealthy lifestyle to trigger Alzheimer’s. However, one gene called apolipoprotein E (APOE) can make a big difference.
No spam, only news and updates.
